GENSPEED Biotech GmbH is offering complete OEM solutions in rapid and multiplexed Point of Care Testing based on the proprietary multiplex Micro ELISA technology platform that is also the basis for a whole CE-IVD certified rapid test portfolio. Our portfolio includes rapid immunoassays like our COVID-19 IgG, TBE IgG xPOC and our newest Vitamin D xPOC Tests but also nucleic acid based tests like the PerioPOC Pro for rapid detection of key pathogens in periodontitis directly at the Dentist's office. GENSPEED Biotech distributes via distribution partners worldwide. GENSPEED Biotech GmbH Gewerbepark 2 • Gebäude B 4261 Rainbach • Austria www.genspeed-biotech.com Location: Gewerbepark 2 • Gebäude B • 4261 Rainbach • Austria CRN: FN 458230v UID: ATU 71391825 CEO: Dr. Max Sonnleitner CFO: Christoph Blaschitz, MSc
Looking for a particular GENSPEED Biotech employee's phone or email?
The GENSPEED Biotech annual revenue was $6 million in 2026.
Max Sonnleitner is the CEO of GENSPEED Biotech.
9 people are employed at GENSPEED Biotech.
The NAICS codes for GENSPEED Biotech are [54, 541, 5417, 541713, 54171].
The SIC codes for GENSPEED Biotech are [873, 87].